Omnicell Inc (NAS:OMCL)

$ 47.01 -0.13 (-0.28%) Market Cap: 2.18 Bil Enterprise Value: 2.21 Bil PE Ratio: 0 PB Ratio: 1.77 GF Score: 73/100

Q3 2024 Omnicell Inc Earnings Call Transcript
Oct 30, 2024

$53.05 (+32.23%)

Earnings
Q2 2024 Omnicell Inc Earnings Call Transcript
Aug 01, 2024

$38.85 (+33.00%)

Earnings
Q1 2024 Omnicell Inc Earnings Call Transcript
May 02, 2024

$29.29 (+7.80%)

Earnings
Q3 2023 Omnicell Inc Earnings Call Transcript
Nov 02, 2023

$29.24 (-18.26%)

Earnings
Q2 2023 Omnicell Inc Earnings Call Transcript
Aug 01, 2023

$61.7 (-2.30%)

Earnings
Omnicell Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023
Q1 2023 Omnicell Inc Earnings Call Transcript
May 02, 2023

$58.46 (-4.90%)

Earnings
Q4 2022 Omnicell Inc Earnings Call Transcript
Feb 28, 2023

$54.44 (+2.79%)

Earnings
Omnicell Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Omnicell Inc Earnings Call Transcript
Nov 02, 2022

$50 (-34.52%)

Earnings
Omnicell to Host Investor Day Transcript
Sep 20, 2022
Q2 2022 Omnicell Inc Earnings Call Transcript
Aug 04, 2022

$110.7 (-0.67%)

Earnings
Omnicell Inc Annual Shareholders Meeting Transcript
May 24, 2022
Q1 2022 Omnicell Inc Earnings Call Transcript
Apr 28, 2022

$107.4 (-0.48%)

Earnings
Q4 2021 Omnicell Inc Earnings Call Transcript
Feb 14, 2022

$147.6 (-4.40%)

Earnings
Omnicell Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 Omnicell Inc Earnings Call Transcript
Nov 02, 2021

$175.34 (+0.50%)

Earnings
Q2 2021 Omnicell Inc Earnings Call Transcript
Jul 29, 2021

$141.84 (-4.27%)

Earnings
Omnicell Inc Annual Shareholders Meeting Transcript
May 25, 2021
Q1 2021 Omnicell Inc Earnings Call Transcript
Apr 29, 2021

$143.86 (+0.96%)

Earnings
Omnicell Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 09, 2021
Q4 2020 Omnicell Inc Earnings Call Transcript
Feb 01, 2021

$122.04 (+3.60%)

Earnings
Omnicell Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Omnicell Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020
Q3 2020 Omnicell Inc Earnings Call Transcript
Oct 27, 2020

$85.59 (+1.77%)

Earnings
Q2 2020 Omnicell Inc Earnings Call Transcript
Jul 28, 2020

$68.95 (+3.53%)

Earnings
Omnicell Inc Annual Shareholders Meeting Transcript
May 26, 2020
Q1 2020 Omnicell Inc Earnings Call Transcript
May 07, 2020

$73.06 (+0.54%)

Earnings
Q4 2019 Omnicell Inc Earnings Call Transcript
Feb 06, 2020

$87.33 (+0.48%)

Earnings
Omnicell Inc at JPMorgan Healthcare Conference Transcript
Jan 16, 2020
Omnicell Inc Investor and Analyst Day at the Annual ASHP Midyear Meeting Transcript
Dec 10, 2019
Q3 2019 Omnicell Inc Earnings Call Transcript
Oct 24, 2019

$75.66 (+2.63%)

Earnings
Q2 2019 Omnicell Inc Earnings Call Transcript
Jul 25, 2019

$70.67 (+0.23%)

Earnings
Q1 2019 Omnicell Inc Earnings Call Transcript
Apr 25, 2019

$77.37 (-0.10%)

Earnings

Omnicell Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 06:50PM GMT

Release Date Price: $125.57 (+1.59%)

Transcript

Steven James Valiquette

Barclays Bank PLC, Research Division - Research Analyst

All right. Okay. Great. Good afternoon, and welcome to the continuation of day 1 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays. Our next session will be with Omnicell. And the stock has really been on a tear recently. It's really essentially doubled over the past 6 months or so. So I'm personally looking forward to hearing more about all the good things happening at the company in this session.

So with us from the company, we have Randall Lipps, the company's Chairman, President, CEO and Founder; Peter Kuipers, the CFO; and also Kathleen Nemeth from Investor Relations. This will be a formal presentation.

Before I turn it to Randall, let me turn it to Kathleen, I think, for a quick safe harbor, and then we'll dive into the presentation.

Kathleen Nemeth

Omnicell, Inc. - VP of IR

Thank you, Steve. Good morning, everyone, and thank you again for hosting us. We're delighted to be here. Before

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.